These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26658107)

  • 1. An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells.
    Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Kumanogoh A; Sugiyama H; Hosen N
    PLoS One; 2015; 10(12):e0144594. PubMed ID: 26658107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.
    Nakata J; Nakano K; Okumura A; Mizutani Y; Kinoshita H; Iwai M; Hasegawa K; Morimoto S; Fujiki F; Tatsumi N; Nakajima H; Nakae Y; Nishida S; Tsuboi A; Oji Y; Oka Y; Sugiyama H; Kumanogoh A; Hosen N
    Leukemia; 2014 Jun; 28(6):1316-25. PubMed ID: 24336127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
    Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakano K; Kinoshita H; Okumura A; Fujioka Y; Urakawa R; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Miyoshi E; Hirata T; Kumanogoh A; Sugiyama H; Hosen N
    PLoS One; 2016; 11(3):e0152326. PubMed ID: 27011118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
    Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
    Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recipient lymphopenia state enhances the expansion and anti-leukemia effect of leukemia specific cytotoxic T lymphocytes].
    Lou JW; Yang JM; Chen L; Jia XY; Zhang WP; Wang JM
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):465-8. PubMed ID: 16383236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.
    Bathe OF; Dalyot-Herman N; Malek TR
    BMC Cancer; 2003 Jul; 3():21. PubMed ID: 12882650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients.
    Gao L; Xue SA; Hasserjian R; Cotter F; Kaeda J; Goldman JM; Dazzi F; Stauss HJ
    Transplantation; 2003 May; 75(9):1429-36. PubMed ID: 12792492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion.
    Ghosh A; Wolenski M; Klein C; Welte K; Blazar BR; Sauer MG
    J Immunother; 2008; 31(2):121-31. PubMed ID: 18481382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
    Stanislawski T; Voss RH; Lotz C; Sadovnikova E; Willemsen RA; Kuball J; Ruppert T; Bolhuis RL; Melief CJ; Huber C; Stauss HJ; Theobald M
    Nat Immunol; 2001 Oct; 2(10):962-70. PubMed ID: 11577350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
    Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
    Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
    Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
    Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
    Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
    J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
    Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
    Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bystander elimination of antigen loss variants in established tumors.
    Spiotto MT; Rowley DA; Schreiber H
    Nat Med; 2004 Mar; 10(3):294-8. PubMed ID: 14981514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.